HRP20120174T1 - Derivat policikličnog cinamida - Google Patents
Derivat policikličnog cinamida Download PDFInfo
- Publication number
- HRP20120174T1 HRP20120174T1 HR20120174T HRP20120174T HRP20120174T1 HR P20120174 T1 HRP20120174 T1 HR P20120174T1 HR 20120174 T HR20120174 T HR 20120174T HR P20120174 T HRP20120174 T HR P20120174T HR P20120174 T1 HRP20120174 T1 HR P20120174T1
- Authority
- HR
- Croatia
- Prior art keywords
- group
- methyl
- phenyl
- methoxy
- vinyl
- Prior art date
Links
- -1 Polycyclic cinnamide derivative Chemical class 0.000 title claims abstract 6
- 125000001424 substituent group Chemical group 0.000 claims abstract 100
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 75
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract 23
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims abstract 18
- 125000005843 halogen group Chemical group 0.000 claims abstract 18
- 150000001875 compounds Chemical class 0.000 claims abstract 17
- 150000003839 salts Chemical class 0.000 claims abstract 16
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims abstract 14
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract 13
- 125000003118 aryl group Chemical group 0.000 claims abstract 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract 10
- 125000003277 amino group Chemical group 0.000 claims abstract 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 7
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims abstract 6
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims abstract 6
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims abstract 6
- 125000006574 non-aromatic ring group Chemical group 0.000 claims abstract 4
- 125000004076 pyridyl group Chemical group 0.000 claims abstract 4
- 125000004844 (C1-C6) alkoxyimino group Chemical group 0.000 claims abstract 3
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims abstract 3
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims abstract 3
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims abstract 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract 3
- 125000005366 cycloalkylthio group Chemical group 0.000 claims abstract 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 3
- 125000000000 cycloalkoxy group Chemical group 0.000 claims abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 2
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract 2
- 229920002554 vinyl polymer Polymers 0.000 claims 72
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 69
- AQWOIRBQLOOZGX-UHFFFAOYSA-N triazolo[1,5-a]pyridine Chemical compound C1=CC=CC2=CN=NN21 AQWOIRBQLOOZGX-UHFFFAOYSA-N 0.000 claims 13
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 6
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims 4
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 3
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 3
- JONHOTQRQYAIBY-FNORWQNLSA-N 2-[(e)-2-[3-fluoro-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(3,4,5-trifluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=NC(C)=CN1C(C(=C1)F)=CC=C1\C=C\C1=NN2CCCC(C=3C=C(F)C(F)=C(F)C=3)C2=N1 JONHOTQRQYAIBY-FNORWQNLSA-N 0.000 claims 2
- YDESGKZGVHWNFJ-SOFGYWHQSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(2,4,6-trifluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=C(F)C=C(F)C=C1F YDESGKZGVHWNFJ-SOFGYWHQSA-N 0.000 claims 2
- BIPXGTARIHCGIF-GQCTYLIASA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(2,4,6-trifluorophenyl)-6,8-dihydro-5h-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCO2)N=C1C2C1=C(F)C=C(F)C=C1F BIPXGTARIHCGIF-GQCTYLIASA-N 0.000 claims 2
- PUSRVRWCIBTGIV-SOFGYWHQSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(3,4,5-trifluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC(F)=C(F)C(F)=C1 PUSRVRWCIBTGIV-SOFGYWHQSA-N 0.000 claims 2
- ICHANYDVCWFHTG-GQCTYLIASA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(3,4,5-trifluorophenyl)-6,8-dihydro-5h-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCO2)N=C1C2C1=CC(F)=C(F)C(F)=C1 ICHANYDVCWFHTG-GQCTYLIASA-N 0.000 claims 2
- NHGUPYCBODUGTD-WUXMJOGZSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(4-methoxyphenyl)-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridin-8-ol Chemical compound C1=CC(OC)=CC=C1C1(O)C2=NC(\C=C\C=3C=C(OC)C(=CC=3)N3C=C(C)N=C3)=NN2CCC1 NHGUPYCBODUGTD-WUXMJOGZSA-N 0.000 claims 2
- MBVUBIYEGJZNOP-WUXMJOGZSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-[4-(trifluoromethoxy)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC=C(OC(F)(F)F)C=C1 MBVUBIYEGJZNOP-WUXMJOGZSA-N 0.000 claims 2
- JNATWVFWZQZUQW-ONNFQVAWSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-[4-(trifluoromethoxy)phenyl]-6,8-dihydro-5h-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCO2)N=C1C2C1=CC=C(OC(F)(F)F)C=C1 JNATWVFWZQZUQW-ONNFQVAWSA-N 0.000 claims 2
- UIVXXXWJGLQGHY-WYMLVPIESA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-naphthalen-1-yl-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridin-8-ol Chemical compound COC1=CC(\C=C\C2=NN3C(C(CCC3)(O)C=3C4=CC=CC=C4C=CC=3)=N2)=CC=C1N1C=NC(C)=C1 UIVXXXWJGLQGHY-WYMLVPIESA-N 0.000 claims 2
- XRGGUPKWDJNMOH-NDENLUEZSA-N 2-[(z)-1-fluoro-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(4-fluorophenyl)-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridin-8-ol Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C(/F)C(=N1)N=C2N1CCCC2(O)C1=CC=C(F)C=C1 XRGGUPKWDJNMOH-NDENLUEZSA-N 0.000 claims 2
- ONJOJETYYKOPEL-SOFGYWHQSA-N 3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(3,4,5-trifluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1CCC2)=NN=C1C2C1=CC(F)=C(F)C(F)=C1 ONJOJETYYKOPEL-SOFGYWHQSA-N 0.000 claims 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- CRJMPGQRVVAATK-VZUCSPMQSA-N 5-[1-(4-fluorophenyl)ethyl]-3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1h-1,2,4-triazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1)=NN=C1C(C)C1=CC=C(F)C=C1 CRJMPGQRVVAATK-VZUCSPMQSA-N 0.000 claims 2
- OXIXYQXOIBERHD-ZRDIBKRKSA-N 8-(2-bromophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC=CC=C1Br OXIXYQXOIBERHD-ZRDIBKRKSA-N 0.000 claims 2
- HOAFPHQBDYDYGC-ONNFQVAWSA-N 8-(4-bromophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,8-dihydro-5h-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCO2)N=C1C2C1=CC=C(Br)C=C1 HOAFPHQBDYDYGC-ONNFQVAWSA-N 0.000 claims 2
- SXOHBPKLSIFMIQ-WUXMJOGZSA-N 8-(4-chlorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC=C(Cl)C=C1 SXOHBPKLSIFMIQ-WUXMJOGZSA-N 0.000 claims 2
- RGMAZZSGAUHFKY-VZUCSPMQSA-N 8-(4-chlorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridin-8-ol Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(O)C1=CC=C(Cl)C=C1 RGMAZZSGAUHFKY-VZUCSPMQSA-N 0.000 claims 2
- AMNONJZOSVUDGL-WUXMJOGZSA-N 8-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-methyl-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(C)C1=CC=C(F)C=C1 AMNONJZOSVUDGL-WUXMJOGZSA-N 0.000 claims 2
- LLDMVSBMTOLQLK-VZUCSPMQSA-N 8-fluoro-8-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(F)C1=CC=C(F)C=C1 LLDMVSBMTOLQLK-VZUCSPMQSA-N 0.000 claims 2
- OONLZXCNCKIBQF-SOFGYWHQSA-N 8-methoxy-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(3,4,5-trifluorophenyl)-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(OC)C1=CC(F)=C(F)C(F)=C1 OONLZXCNCKIBQF-SOFGYWHQSA-N 0.000 claims 2
- HHZBYCZWQLBOCA-NTUHNPAUSA-N 8-methoxy-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(4-methoxyphenyl)-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=CC(OC)=CC=C1C1(OC)C2=NC(\C=C\C=3C=C(OC)C(=CC=3)N3C=C(C)N=C3)=NN2CCC1 HHZBYCZWQLBOCA-NTUHNPAUSA-N 0.000 claims 2
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 claims 2
- 201000010374 Down Syndrome Diseases 0.000 claims 2
- 206010044688 Trisomy 21 Diseases 0.000 claims 2
- 125000005133 alkynyloxy group Chemical group 0.000 claims 2
- 206010002022 amyloidosis Diseases 0.000 claims 2
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 claims 2
- 125000005149 cycloalkylsulfinyl group Chemical group 0.000 claims 2
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 150000003852 triazoles Chemical class 0.000 claims 2
- FIHZRPHAOVYWEH-UDWIEESQSA-N (8e)-2-[(4-fluorophenyl)methyl]-8-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C(C1=N2)/CCCN1N=C2CC1=CC=C(F)C=C1 FIHZRPHAOVYWEH-UDWIEESQSA-N 0.000 claims 1
- YHFGELPHHDMZHO-YICVCXCLSA-N (8r)-8-(4-chlorophenyl)-3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C1([C@@H]2C3=NN=C(N3CCC2)/C=C/C=2C=C(C(=CC=2)N2C=C(C)N=C2)OC)=CC=C(Cl)C=C1 YHFGELPHHDMZHO-YICVCXCLSA-N 0.000 claims 1
- YHFGELPHHDMZHO-BOQJPMNSSA-N (8s)-8-(4-chlorophenyl)-3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine Chemical compound C1([C@H]2C3=NN=C(N3CCC2)/C=C/C=2C=C(C(=CC=2)N2C=C(C)N=C2)OC)=CC=C(Cl)C=C1 YHFGELPHHDMZHO-BOQJPMNSSA-N 0.000 claims 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 1
- NTSFRWOCQNZBPE-ONNFQVAWSA-N 1-(4-fluorophenyl)-3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,7-dihydro-5h-imidazo[1,5-a]pyrazin-8-one Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1CCNC(=O)C1=1)=NC=1C1=CC=C(F)C=C1 NTSFRWOCQNZBPE-ONNFQVAWSA-N 0.000 claims 1
- MKOUANAAYOBUQS-ONNFQVAWSA-N 1-(4-fluorophenyl)-3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,8-dihydro-5h-imidazo[5,1-c][1,4]oxazine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1CCOCC1=1)=NC=1C1=CC=C(F)C=C1 MKOUANAAYOBUQS-ONNFQVAWSA-N 0.000 claims 1
- RMMNVBJKJSXECZ-XYOKQWHBSA-N 1-[(4-fluorophenyl)methyl]-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-4,5-dimethylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C1=NC(C)=C(C)N1CC1=CC=C(F)C=C1 RMMNVBJKJSXECZ-XYOKQWHBSA-N 0.000 claims 1
- RCLLKUOOBHJCTE-PKNBQFBNSA-N 1-[2-methoxy-4-[(e)-2-(5-phenyl-1h-imidazol-2-yl)ethenyl]phenyl]-4-methylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(NC=1)=NC=1C1=CC=CC=C1 RCLLKUOOBHJCTE-PKNBQFBNSA-N 0.000 claims 1
- FAEGAULHOWGHCT-PKNBQFBNSA-N 1-[2-methoxy-4-[(e)-2-[5-(2-methoxyphenyl)-1h-imidazol-2-yl]ethenyl]phenyl]-4-methylimidazole Chemical compound COC1=CC=CC=C1C1=CNC(\C=C\C=2C=C(OC)C(=CC=2)N2C=C(C)N=C2)=N1 FAEGAULHOWGHCT-PKNBQFBNSA-N 0.000 claims 1
- DMMLTKBRQGWGBC-CSKARUKUSA-N 1-[2-methoxy-4-[(e)-2-[5-(3-methoxyphenyl)-1h-imidazol-2-yl]ethenyl]phenyl]-4-methylimidazole Chemical compound COC1=CC=CC(C=2N=C(\C=C\C=3C=C(OC)C(=CC=3)N3C=C(C)N=C3)NC=2)=C1 DMMLTKBRQGWGBC-CSKARUKUSA-N 0.000 claims 1
- UMWLWXCNEOMVEM-VZUCSPMQSA-N 1-[2-methoxy-4-[(e)-2-[5-(4-methoxyphenyl)-1h-imidazol-2-yl]ethenyl]phenyl]-4-methylimidazole Chemical compound C1=CC(OC)=CC=C1C1=CNC(\C=C\C=2C=C(OC)C(=CC=2)N2C=C(C)N=C2)=N1 UMWLWXCNEOMVEM-VZUCSPMQSA-N 0.000 claims 1
- QKKCRIRBDWMEJO-GQCTYLIASA-N 1-[4-[(e)-2-(5-chloro-1h-imidazol-2-yl)ethenyl]-2-methoxyphenyl]-4-methylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C1=NC(Cl)=CN1 QKKCRIRBDWMEJO-GQCTYLIASA-N 0.000 claims 1
- JMIMRKFFYGMRAA-ONNFQVAWSA-N 1-[4-[(e)-2-[5-(4-chlorophenyl)-1h-imidazol-2-yl]ethenyl]-2-methoxyphenyl]-4-methylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(NC=1)=NC=1C1=CC=C(Cl)C=C1 JMIMRKFFYGMRAA-ONNFQVAWSA-N 0.000 claims 1
- JTFWKEFCHFOGHE-ONNFQVAWSA-N 1-[4-[(e)-2-[5-(4-fluorophenyl)-1h-imidazol-2-yl]ethenyl]-2-methoxyphenyl]-4-methylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(NC=1)=NC=1C1=CC=C(F)C=C1 JTFWKEFCHFOGHE-ONNFQVAWSA-N 0.000 claims 1
- HEPATOAZXTVVDH-UXBLZVDNSA-N 1-[4-[(e)-2-[5-[(4-fluorophenyl)methyl]-1h-imidazol-2-yl]ethenyl]-2-methoxyphenyl]-4-methylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(NC=1)=NC=1CC1=CC=C(F)C=C1 HEPATOAZXTVVDH-UXBLZVDNSA-N 0.000 claims 1
- GTBMIVYKTVKBQE-UHFFFAOYSA-N 1h-triazolo[1,5-a]azepine Chemical compound C1=CC=CN2NN=CC2=C1 GTBMIVYKTVKBQE-UHFFFAOYSA-N 0.000 claims 1
- GQCSLAPDYCEANX-AATRIKPKSA-N 2-[(e)-2-[2-fluoro-5-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(3,4,5-trifluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC(F)=C(F)C(F)=C1 GQCSLAPDYCEANX-AATRIKPKSA-N 0.000 claims 1
- FRSBIDGXMBDIFI-JXMROGBWSA-N 2-[(e)-2-[2-fluoro-5-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(4-fluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC=C(F)C=C1 FRSBIDGXMBDIFI-JXMROGBWSA-N 0.000 claims 1
- DSOHYMJIFPTMDI-RUDMXATFSA-N 2-[(e)-2-[2-fluoro-5-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(4-fluorophenyl)-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridin-8-ol Chemical compound FC=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(O)C1=CC=C(F)C=C1 DSOHYMJIFPTMDI-RUDMXATFSA-N 0.000 claims 1
- WGVNUPKENODMAA-ZRDIBKRKSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1-methyl-4-phenylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N(C=1)C)=NC=1C1=CC=CC=C1 WGVNUPKENODMAA-ZRDIBKRKSA-N 0.000 claims 1
- HBYWSYHJIUYQDC-ZRDIBKRKSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1-methyl-5-phenylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1C)=NC=C1C1=CC=CC=C1 HBYWSYHJIUYQDC-ZRDIBKRKSA-N 0.000 claims 1
- ORKJTDDBXWRNFY-GQCTYLIASA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-7-(3,4,5-trifluorophenyl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CC2)N=C1C2C1=CC(F)=C(F)C(F)=C1 ORKJTDDBXWRNFY-GQCTYLIASA-N 0.000 claims 1
- OZAUYOSBLXLUTO-ACCUITESSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(2-methoxyphenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC=CC=C1C1C2=NC(\C=C\C=3C=C(OC)C(=CC=3)N3C=C(C)N=C3)=NN2CCC1 OZAUYOSBLXLUTO-ACCUITESSA-N 0.000 claims 1
- MLDLRNATTWHWBE-FNORWQNLSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(3,4,5-trifluorophenyl)-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridin-8-ol Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(O)C1=CC(F)=C(F)C(F)=C1 MLDLRNATTWHWBE-FNORWQNLSA-N 0.000 claims 1
- GNQGMJWSSMNPIR-YRNVUSSQSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-(4-methylphenyl)-6,8-dihydro-5h-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCO2)N=C1C2C1=CC=C(C)C=C1 GNQGMJWSSMNPIR-YRNVUSSQSA-N 0.000 claims 1
- TXYJGXVJRDEGPF-FYWRMAATSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-naphthalen-1-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC(\C=C\C2=NN3CCCC(C3=N2)C=2C3=CC=CC=C3C=CC=2)=CC=C1N1C=NC(C)=C1 TXYJGXVJRDEGPF-FYWRMAATSA-N 0.000 claims 1
- WGEOZEVVAFYXTQ-ZRDIBKRKSA-N 2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-8-phenyl-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(C#N)C1=CC=CC=C1 WGEOZEVVAFYXTQ-ZRDIBKRKSA-N 0.000 claims 1
- DHLFNYGRJWGLJB-AATRIKPKSA-N 2-[(e)-2-[5-methoxy-6-(4-methylimidazol-1-yl)pyridin-3-yl]ethenyl]-8-(3,4,5-trifluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1N=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC(F)=C(F)C(F)=C1 DHLFNYGRJWGLJB-AATRIKPKSA-N 0.000 claims 1
- HCSNRLMIMJJKHQ-SNAWJCMRSA-N 2-[(e)-2-[5-methoxy-6-(4-methylimidazol-1-yl)pyridin-3-yl]ethenyl]-8-(3,4,5-trifluorophenyl)-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridin-8-ol Chemical compound C=1N=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(O)C1=CC(F)=C(F)C(F)=C1 HCSNRLMIMJJKHQ-SNAWJCMRSA-N 0.000 claims 1
- YLYQTLPNUAEHJU-VZUCSPMQSA-N 2-[4-(4-fluorophenyl)-5-(methoxymethyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]imidazol-1-yl]ethanol Chemical compound OCCN1C(COC)=C(C=2C=CC(F)=CC=2)N=C1\C=C\C(C=C1OC)=CC=C1N1C=NC(C)=C1 YLYQTLPNUAEHJU-VZUCSPMQSA-N 0.000 claims 1
- NEQSYUAQGMCWJD-ACCUITESSA-N 3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1-methyl-5-(1-phenylethyl)-1,2,4-triazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1C)N=C1C(C)C1=CC=CC=C1 NEQSYUAQGMCWJD-ACCUITESSA-N 0.000 claims 1
- OSOKWONGWUVJJK-WYMLVPIESA-N 3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1-phenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1CCCCC1=1)=NC=1C1=CC=CC=C1 OSOKWONGWUVJJK-WYMLVPIESA-N 0.000 claims 1
- AJICJFMNJWNYHY-ZRDIBKRKSA-N 3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5-(1-phenylethyl)-1h-1,2,4-triazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1)=NN=C1C(C)C1=CC=CC=C1 AJICJFMNJWNYHY-ZRDIBKRKSA-N 0.000 claims 1
- AJICJFMNJWNYHY-DPCFLFMUSA-N 3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5-[(1r)-1-phenylethyl]-1h-1,2,4-triazole Chemical compound C1([C@@H](C)C2=NN=C(N2)/C=C/C=2C=C(C(=CC=2)N2C=C(C)N=C2)OC)=CC=CC=C1 AJICJFMNJWNYHY-DPCFLFMUSA-N 0.000 claims 1
- AJICJFMNJWNYHY-JICACKBISA-N 3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5-[(1s)-1-phenylethyl]-1h-1,2,4-triazole Chemical compound C1([C@H](C)C2=NN=C(N2)/C=C/C=2C=C(C(=CC=2)N2C=C(C)N=C2)OC)=CC=CC=C1 AJICJFMNJWNYHY-JICACKBISA-N 0.000 claims 1
- UYSGVEBSVPGEBR-GQCTYLIASA-N 3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-7-(3,4,5-trifluorophenyl)-6,7-dihydro-5h-pyrrolo[2,1-c][1,2,4]triazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1CC2)=NN=C1C2C1=CC(F)=C(F)C(F)=C1 UYSGVEBSVPGEBR-GQCTYLIASA-N 0.000 claims 1
- PWVHPGTXAKBAQE-VZUCSPMQSA-N 4-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1-methylimidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N(C=1)C)=NC=1C1=CC=C(F)C=C1 PWVHPGTXAKBAQE-VZUCSPMQSA-N 0.000 claims 1
- ZSTZSTATBPOYBI-ONNFQVAWSA-N 4-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1h-imidazole-5-carboxylic acid Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1)=NC(C(O)=O)=C1C1=CC=C(F)C=C1 ZSTZSTATBPOYBI-ONNFQVAWSA-N 0.000 claims 1
- BPVUOEALSVTFFU-VZUCSPMQSA-N 4-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5-methyl-1h-imidazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1)=NC(C)=C1C1=CC=C(F)C=C1 BPVUOEALSVTFFU-VZUCSPMQSA-N 0.000 claims 1
- OCSVRGARPGLGPU-RIYZIHGNSA-N 4-[2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-yl]-n,n-dimethylaniline Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC=C(N(C)C)C=C1 OCSVRGARPGLGPU-RIYZIHGNSA-N 0.000 claims 1
- TVIKCEPHNNHTTN-XYOKQWHBSA-N 4-[2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-yl]benzonitrile Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC=C(C#N)C=C1 TVIKCEPHNNHTTN-XYOKQWHBSA-N 0.000 claims 1
- DYFPUKWFZBWNMO-UXBLZVDNSA-N 4-[2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,8-dihydro-5h-[1,2,4]triazolo[5,1-c][1,4]oxazin-8-yl]benzonitrile Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCO2)N=C1C2C1=CC=C(C#N)C=C1 DYFPUKWFZBWNMO-UXBLZVDNSA-N 0.000 claims 1
- BWDBBDXCHPPZNB-SOFGYWHQSA-N 4-[3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1h-1,2,4-triazol-5-yl]-4-(3,4,5-trifluorophenyl)butan-1-ol Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1)=NN=C1C(CCCO)C1=CC(F)=C(F)C(F)=C1 BWDBBDXCHPPZNB-SOFGYWHQSA-N 0.000 claims 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims 1
- WTBXBULIQGJHNQ-ACCUITESSA-N 5-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1-methyl-3-(1-phenylethyl)-1,2,4-triazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N(N=1)C)=NC=1C(C)C1=CC=CC=C1 WTBXBULIQGJHNQ-ACCUITESSA-N 0.000 claims 1
- SSNFDOZTFDCJFS-WUXMJOGZSA-N 5-[methoxy-(4-methoxyphenyl)methyl]-3-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1h-1,2,4-triazole Chemical compound C=1C=C(OC)C=CC=1C(OC)C(NN=1)=NC=1\C=C\C(C=C1OC)=CC=C1N1C=NC(C)=C1 SSNFDOZTFDCJFS-WUXMJOGZSA-N 0.000 claims 1
- YJCYLFYNGBSXQJ-VZUCSPMQSA-N 7-(4-fluorophenyl)-7-methoxy-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6-dihydropyrrolo[1,2-b][1,2,4]triazole Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCC2(OC)C1=CC=C(F)C=C1 YJCYLFYNGBSXQJ-VZUCSPMQSA-N 0.000 claims 1
- LVLVBMKGPNNHNM-UXBLZVDNSA-N 8-(3,4-difluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC2)N=C1C2C1=CC=C(F)C(F)=C1 LVLVBMKGPNNHNM-UXBLZVDNSA-N 0.000 claims 1
- KACXLOORNWFOCL-WUXMJOGZSA-N 8-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-5,6-dihydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCC=2)N=C1C=2C1=CC=C(F)C=C1 KACXLOORNWFOCL-WUXMJOGZSA-N 0.000 claims 1
- AGCGZSWEZREMJY-VZUCSPMQSA-N 8-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridin-8-ol Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(O)C1=CC=C(F)C=C1 AGCGZSWEZREMJY-VZUCSPMQSA-N 0.000 claims 1
- HBVBZAZTCCELNB-WUXMJOGZSA-N 8-(4-fluorophenyl)-8-methoxy-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=N1)N=C2N1CCCC2(OC)C1=CC=C(F)C=C1 HBVBZAZTCCELNB-WUXMJOGZSA-N 0.000 claims 1
- SRZMIJBELJDWFT-XBXARRHUSA-N 8-(6-chloropyridin-3-yl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-6,8-dihydro-5h-[1,2,4]triazolo[5,1-c][1,4]oxazine Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(=NN1CCO2)N=C1C2C1=CC=C(Cl)N=C1 SRZMIJBELJDWFT-XBXARRHUSA-N 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims 1
- ZXCOIUJZPVNJFO-VZUCSPMQSA-N methyl 4-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1h-imidazole-5-carboxylate Chemical compound N1C(C=2C=CC(F)=CC=2)=C(C(=O)OC)N=C1\C=C\C(C=C1OC)=CC=C1N1C=NC(C)=C1 ZXCOIUJZPVNJFO-VZUCSPMQSA-N 0.000 claims 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N methylimidazole Natural products CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 claims 1
- DEONRSKBUDATDN-ONNFQVAWSA-N n-(2-chloroethyl)-4-(4-fluorophenyl)-2-[(e)-2-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]ethenyl]-1h-imidazole-5-carboxamide Chemical compound C=1C=C(N2C=C(C)N=C2)C(OC)=CC=1\C=C\C(N1)=NC(C(=O)NCCCl)=C1C1=CC=C(F)C=C1 DEONRSKBUDATDN-ONNFQVAWSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- POFDSYGXHVPQNX-UHFFFAOYSA-N triazolo[1,5-a]pyrimidine Chemical compound C1=CC=NC2=CN=NN21 POFDSYGXHVPQNX-UHFFFAOYSA-N 0.000 claims 1
- LENLQGBLVGGAMF-UHFFFAOYSA-N tributyl([1,2,4]triazolo[1,5-a]pyridin-6-yl)stannane Chemical compound C1=C([Sn](CCCC)(CCCC)CCCC)C=CC2=NC=NN21 LENLQGBLVGGAMF-UHFFFAOYSA-N 0.000 claims 1
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Spoj prikazan formulom (I): ili njegova farmakološki prihvatljiva sol, naznačen time, daAr, predstavlja imidazolnu skupinu koja se može supstituirati s jednom ili dvije supstituenta odabranih iz skupine koju čine (1) atom vodika, (2) atom halogena, (3) C3-8 cikloalkilna skupina, (4) C2-6 alkenilna skupina, (5) C2-6 alkinilna skupina i (6) C1-6 alkilna skupina (pri čemu se C1-6 alkilna skupina može supstituirati s 1 do 3 atoma halogena), Ar2 predstavlja fenilnu skupinu ili piridinilnu skupinu koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine koju čine (1) atom vodika, (2) atom halogena, (3) cijano skupina i (4) C1-6 alkoksi skupina, X1 predstavlja -CR3=CR4- (pri čemu R3 i R4 predstavljaju (1) atom vodika, (2) C1-6 alkilnu skupinu ili (3) C1-6 alkoksi skupinu, ili (4) atom halogena), iHet je monovalentan i predstavlja (1) 5-eročlanu aromatsku heterocikličku skupinu, (2) 5- eročlanu aromatsku heterocikličku skupinu kondenziranu sa 6- do 14-eročlanom nearomatskom prstenastom ugljikovodičnom skupinom ili (3) 5-eročlanu aromatsku prstenastu heterocikličku skupinu kondenziranu sa 5- do 14-eročlanom nearomatskom heterocikličkom skupinom, koja se može supstituirati s 1 do 3 supstituenta odabranih iz sljedeće skupine supstituenta A4; Skupina supstituenta A4: (1) atom vodika, (2) atom halogena, (3) hidroksilna skupina, (4) cijano skupina, (5) nitro skupina, (6) C3-8 cikloalkilna skupina, (7) C2-6 alkenilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (8) a C2-6 alkinilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (9) C3-8 cikloalkoksi skupina, (10) C3-8 cikloalkiltio skupina, (11) formilna skupina, (12) C1-6 alkilkarbonilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (13) C1-6 alkiltio skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (14) C1-6 alkilsulfinilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (15) C1-6 alkilsulfonilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (16) hidroksiimino skupina, (17) C1-6 alkoksiimino skupina, (18) C1-6 alkilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (19) C1-6 alkoksi skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (20) amino skupina koja se može supstituirati s jednom ili dvije supstituenta odabranih iz skupine supstituenata A5, (21) karbamoilna skupina koja se može supstituirati s jednom ili dvije supstituenta odabranih iz skupine supstituenata A5, (22) 6- do 14-eročlana aromatska prstenasta ugljikovodična skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (23) 5- do 14-eročlana aromatska heterociklička skupina koja se može supstituirati s 1 do 3 supst
Claims (17)
1. Spoj prikazan formulom (I):
[image]
ili njegova farmakološki prihvatljiva sol, naznačen time, da
Ar, predstavlja imidazolnu skupinu koja se može supstituirati s jednom ili dvije supstituenta odabranih iz skupine koju čine (1) atom vodika, (2) atom halogena, (3) C3-8 cikloalkilna skupina, (4) C2-6 alkenilna skupina, (5) C2-6 alkinilna skupina i (6) C1-6 alkilna skupina (pri čemu se C1-6 alkilna skupina može supstituirati s 1 do 3 atoma halogena),
Ar2 predstavlja fenilnu skupinu ili piridinilnu skupinu koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine koju čine (1) atom vodika, (2) atom halogena, (3) cijano skupina i (4) C1-6 alkoksi skupina,
X1 predstavlja -CR3=CR4- (pri čemu R3 i R4 predstavljaju (1) atom vodika, (2) C1-6 alkilnu skupinu ili (3) C1-6 alkoksi skupinu, ili (4) atom halogena), i
Het je monovalentan i predstavlja (1) 5-eročlanu aromatsku heterocikličku skupinu, (2) 5- eročlanu aromatsku heterocikličku skupinu kondenziranu sa 6- do 14-eročlanom nearomatskom prstenastom ugljikovodičnom skupinom ili (3) 5-eročlanu aromatsku prstenastu heterocikličku skupinu kondenziranu sa 5- do 14-eročlanom nearomatskom heterocikličkom skupinom, koja se može supstituirati s 1 do 3 supstituenta odabranih iz sljedeće skupine supstituenta A4;
Skupina supstituenta A4: (1) atom vodika, (2) atom halogena, (3) hidroksilna skupina, (4) cijano skupina, (5) nitro skupina, (6) C3-8 cikloalkilna skupina, (7) C2-6 alkenilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (8) a C2-6 alkinilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (9) C3-8 cikloalkoksi skupina, (10) C3-8 cikloalkiltio skupina, (11) formilna skupina, (12) C1-6 alkilkarbonilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (13) C1-6 alkiltio skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (14) C1-6 alkilsulfinilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (15) C1-6 alkilsulfonilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (16) hidroksiimino skupina, (17) C1-6 alkoksiimino skupina, (18) C1-6 alkilna skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (19) C1-6 alkoksi skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (20) amino skupina koja se može supstituirati s jednom ili dvije supstituenta odabranih iz skupine supstituenata A5, (21) karbamoilna skupina koja se može supstituirati s jednom ili dvije supstituenta odabranih iz skupine supstituenata A5, (22) 6- do 14-eročlana aromatska prstenasta ugljikovodična skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (23) 5- do 14-eročlana aromatska heterociklička skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (24) 6- do 14-eročlana nearomatska prstenasta ugljikovodična skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (25) 5- do 14-eročlana nearomatska heterociklička skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A5, (26) C2-6 alkeniloksi skupina, (27) C2-6 alkiniloksi skupina, (28) C3-8 cikloalkilsulfinilna skupina, (29) C3-8 cikloalkilsulfonilna skupina, (30) -X-A (pri čemu X predstavlja imino skupinu, -O- ili -S-, a A predstavlja 6- do 14-eročlanu aromatsku prstenastu ugljikovodičnu skupinu ili 5- do 14-eročlanu aromatsku heterocikličku skupinu koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6), (31) -CO-A (pri čemu je A definiran jednako kao u prethodnom tekstu), (32) =CH-A (pri čemu je A definiran jednako kao u prethodnom tekstu), (33) karboksilna skupina i (34) C1-6 alkoksikarbonilna skupina.
Skupina supstituenta A5: (1) atom vodika, (2) atom halogena, (3) hidroksilna skupina, (4) cijano skupina, (5) nitro skupina, (6) C3-8 cikloalkilna skupina, (7) C2-6 alkenilna skupina, (8) C2-6 alkinilna skupina, (9) C3-8 cikloalkoksi skupina, (10) C3-8 cikloalkiltio skupina, (11) formilna skupina, (12) C1-6 alkilkarbonilna skupina, (13) C1-6 alkiltio skupina, (14) C1-6 alkilsulfinilna skupina, (15) C1-6 alkilsulfonilna skupina, (16) hidroksiimino skupina, (17) C1-6 alkoksiimino skupina, (18) C1-6 alkilna skupina (pri čemu se C1-6 alkilna skupina može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6, 6- do 14-eročlana aromatska prstenasta ugljikovodična skupina (pri čemu se 6- do 14-eročlana aromatska prstenasta ugljikovodična skupina može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6) i 5- do 14-eročlana aromatska heterociklička skupina (pri čemu se 5- do 14-eročlana aromatska heterociklička skupina može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6)), (19) C1-6 alkoksi skupina (pri čemu se C1-6 alkoksi skupina može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6, 6- do 14-eročlana aromatska prstenasta ugljikovodična skupina (pri čemu se 6- do 14-eročlana aromatska prstenasta ugljikovodična skupina može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6) i 5- do 14-eročlana aromatska heterociklička skupina (pri čemu se 5- do 14- eročlana aromatska heterociklička skupina može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6)), (20) amino skupina koja se može supstituirati s jednom ili dvije C1-6 alkilne skupine, (21) karbamoilna skupina koja se može supstituirati s jednom ili dvije C1-6 alkilne skupine, (22) 6- do 14-eročlana aromatska prstenasta ugljikovodična skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6, (23) 5- do 14- eročlana aromatska heterociklička skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6, (24) 6- do 14-eročlana nearomatska prstenasta ugljikovodična skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6, (25) 5- do 14-eročlana nearomatska heterociklička skupina koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6, (26) C2-6 alkeniloksi skupina, (27) C2-6 alkiniloksi skupina, (28) C3-8 cikloalkilsulfinilna skupina, (29) C3-8 cikloalkilsulfonilna skupina, (30) -X-A (pri čemu X predstavlja imino skupinu, -O- ili -S-, a A predstavlja 6- do 14-eročlanu aromatsku prstenastu ugljikovodičnu skupinu ili 5- do 14-eročlanu aromatsku heterocikličku skupinu koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A6), (31) -CO-A (pri čemu je A definiran jednako kao u prethodnom tekstu) i (32) =CH-A (pri čemu je A definiran jednako kao u prethodnom tekstu).
Skupina supstituenta A6: (1) atom vodika, (2) atom halogena, (3) hidroksilna skupina, (4) cijano skupina, (5) amino skupina koja se može supstituirati s jednom ili dvije C1-6 alkilne skupine, (6) C1-6 alkilna skupina (pri čemu se C1-6 alkilna skupina može supstituirati s 1 do 3 supstituenta odabranih iz skupine koju čine atom halogena, hidroksilna skupina, cijano skupina, amino skupina koja se može supstituirati s jednom ili dvije C1-6 alkilne skupine) i (7) C1-6 alkoksi skupina (pri čemu se C1-6 alkoksi skupina može supstituirati s 1 do 3 supstituenta odabranih iz skupine koju čine atom halogena, hidroksilna skupina, cijano skupina, amino skupina koja se može supstituirati s jednom ili dvije C1-6 alkilne skupine).
2. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 1, naznačen time, da je Ar1 supstituiran s C1-6 alkilnom skupinom.
3. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 1 ili patentni zahtjev 2, naznačen time, da je Ar2 piridinilna skupina.
4. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 1 ili patentni zahtjev 2, naznačen time, da je Ar2 fenilna skupina.
5. Spoj ili njegova farmakološki prihvatljiva sol u skladu s jednim od patentnih zahtjeva 1 i 3 do 4, naznačen time, da je Ar2 supstituiran s C1-6 alkoksi skupinom.
6. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 1, naznačen time, da X1 je -CH=CH-.
7. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 1, naznačen time, da je Het skupina prikazana formulom:
[image]
koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A4, pri čemu
--- predstavlja jednostruku vezu ili dvostruku vezu, X3 predstavlja metinsku skupinu ili metilensku skupinu, imino skupinu, atoma kisika, atom sumpora ili -SO2-, koji se može supstituirati sa supstituentom odabranim iz skupine supstituenata A4, Y6 predstavlja atom ugljika ili atom dušika, a na i nb neovisno predstavljaju cijeli broj u rasponu od 0 do 3.
8. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 7, naznačen time, da je Het skupina prikazana formulom:
[image]
koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A4, pri čemu su R6 i R7 jednaki ili različiti, a svaki predstavlja supstituent odabran iz skupine supstituenata A4, X3 je definiran jednako kao u patentnom zahtjevu 7, a nC predstavlja cijeli broj u rasponu od 0 do 2.
9. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 8, naznačen time, da R6 predstavlja 6- do 14-eročlanu aromatsku prstenastu ugljikovodičnu skupinu ili 5- do 14-eročlanu aromatsku heterocikličku skupinu koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine supstituenata A4.
10. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 8, naznačen time, da R6 predstavlja fenilnu skupinu, piridinilnu skupinu ili naftilnu skupinu koja se može supstituirati s 1 do 3 supstituenta odabranih iz skupine koju čine (1) atom vodika, (2) atom halogena, (3) cijano skupina, (4) C1-6 alkoksi skupina (pri čemu se C1-6 alkoksi skupina može supstituirati s jednim do tri atoma halogena), (5) C1-6 alkilna skupina (pri čemu se C1-6 alkilna skupina može supstituirati s 1 do 3 atoma halogena, i (6) amino skupina koja se može supstituirati s jednom ili dvije C1-6 alkilne skupine.
11. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 8, naznačen time, da R7 predstavlja supstituentsku skupinu odabranu iz skupine koju čine (1) atom vodika, (2) atom halogena, (3) hidroksilna skupina, (4) cijano skupina, (5) C1-6 alkilna skupina, (6) C2-6 alkenilna skupina, (7) C2-6 alkinilna skupina, (8) C1-6 alkoksi skupina i (9) amino skupina koja se može supstituirati s jednom ili dvije C1-6 alkilne skupine.
12. Spoj ili njegova farmakološki prihvatljiva sol u skladu s patentnim zahtjevom 1, naznačen time, da je taj spoj odabran iz sljedeće skupina:
1) 4-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol,
2) 4-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-1H-imidazol,
3) 2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-5-fenil-1H-imidazol,
4) 2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4-fenil-1H-imidazol,
5) 2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-4-fenil-1H-imidazol,
6) metil-5-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol-4-karboksilat,
7) 5-(9-fluorfenil)-2-{(E)-2-[3-metoksi-4-(9-metil-1H-imidazol-1-il)fenil]vinil}-(1H-imidazol-4-il)metanol,
8) 5-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil)-1H-imidazol-4-karboksilna kiselina,
9) 5-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol-4-karboksilna kiselina (2-kloretil)amid,
10) 1-(4-fluorfenil)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-6,7-dihidro-5H-imidazo[1,5-a]pirazin-8-on,
11) 1-(4-fluorfenil)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-7-metil-6,7-dihidro-5H-imidazo[1,5-a]pirazin-8-on,
12) 1-(4-fluorfenil)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidroimidazo[5,1-c][1,4]oksazin-8-on,
13) 1-(4-fluorfenil)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidro-8H-imidazo[5,1-c][1,4]oksazin,
14) 2-{4-(4-fluorfenil)-5-metoksimetil-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}imidazol-1-il}etanol,
15) 1-(9-fluorfenil)-3-{(E)-2-[3-metoksi-4-(9-metil-1H-imidazol-1-il)fenil]vinil}-7-metil-5,6,7,8-tetrahidroimidazo[1,5-a]pirazin,
16) 3-(3-fluorfenil)-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4H-[1,2,4]triazol,
17) 3-(9-fluorbenzil)-5-{(E)-2-[3-metoksi-9-(4-metil-1H-imidazol-1-il)fenil]vinil}-4H-[1,2,4]triazol,
18) 1-(4-fluorbenzil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4,5-dimetil-1H- imidazol,
19) 3-[1-(4-fluorfenil)etil]-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4H-[1,2,4] triazol,
20) 3-[2-(4-fluorfenil)etil]-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4H-[1.2.4]triazol,
21) 4-(4-fluorbenzil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil)-1H-imidazol,
22) 5-(4-fluorbenzil)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-1H-[1.2.4]triazol,
23) 3-(4-fluorbenzil)-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-1H-[1.2.4]triazol,
24) (+)-3-[1-(4-fluorfenil)etil]-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4H-[1,2,4] triazol,
25) (-)-3-[1-(4-fluorfenil)etil]-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4H-[1,2,4) triazol,
26) 5-[1-(4-fluorfenil)etil]-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-1H-[1.2.4]triazol,
27) 3-[1-(4-fluorfenil)etil]-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-1H-[1.2.4]triazol,
28) 5-[1-(4-fluorfenil)etil]-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-1H-[1.2.4]triazol,
29) 3-[1-(4-fluorfenil)etil]-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil)-1-metil-1H-[1.2.4]triazol,
30) (+)-3-[1-(4-fluorfenil)etil]-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4-metil-4H-[1,2,9]triazol,
31) (-)-3-[1-(4-fluorfenil)etil]-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4-metil-4H-[1.2.4]triazol,
32) 3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5-(1-feniletil)-4H-[1,2,4]triazol,
33) 3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-5-(1-feniletil)-1H-[1,2,4]triazol,
34) 5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-metil-3-(1-feniletil)-1H-[1,2,4] triazol,
35) 3-(4-fluorfenil)-5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4H-[1,2,4]triazol,
36) 5-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4-metil-1H-imidazol,
37) 3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5-(1-metil-1-feniletil)-4H-[1,2,4]triazol,
38) 3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-fenil-5,6,7,8-tetrahidroimidazo[1,5-a]piridin,
39) (+)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
40) (-)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
41) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
42) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
43) (+)-5-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-meti-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
44) (-)-5-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
45) (+)-2-{(Z)-1-fluoro-2-{3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3.4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
46) (-)-2-{(Z)-1-fluoro-2-[3-metoksi-4-(9-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
47) (+)-2-((E)-2-[5-metoksi-6-(4-metil-1H-imidazol-1-il)piridin-3-il]vinil)-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
48) (-)-2-{(E)-2-{5-metoksi-6-(4-metil-1H-imidazol-1-il)piridin-3-il]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,9]triazolo[1,5-a]piridin,
49) (+)-2-{(E)-2-[3-fluoro-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
50) (-)-2-{(E)-2-[3-fluoro-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro [1,2,4]triazolo[1,5-a]piridin,
51) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(2,4,6-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
52) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(2,4,6-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
53) 7-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-6,7-dihidro-5H-pirolo[1,2-b][1,2,9]triazol-7-ol,
54) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
55) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
56) (+)-2-{(E)-2-[2-fluoro-5-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
57) (-)-2-{(E)-2-[2-fluoro-5-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
58) (-)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,9]triazolo[1,5-a]piridin-8-ol,
59) (+)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
60) (+)-8-fluoro-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
61) (-)-8-fluoro-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
62) 8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidro[1,2,4]triazolo[1,5-a]piridin,
63) (-)-2-{(E)-2-[3-metoksi-9-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-metoksifenil)-5,6,7,8-tetrahidro-[1,2,4]triazolo[1,5-a]piridin,
64) (+)-2-((E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-metoksifenil)-5,6,7,8-tetrahidro-[1,2,4]triazolo[1,5-a]piridin,
65) (-)-2-{(E)-2-(3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil)vinil}-8-(3,4,5-trifluorfenil)-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
66) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin.
67) (-)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-metil-5,6,7,8-tetrahidro-[1,2,4]triazolo[1,5-a]piridin,
68) (+)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-metil-5,6,7,8- tetrahidro-[1,2,4]triazolo[1,5-a]piridin,
69) 2-(4-fluorbenzil)-8-{1-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]-(E)-metiliden}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
70) 3-(4-fluorbenzil)-8-{1-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]-(E)-metiliden}-5,6,7,8-tetrahidro[1,2,9]triazolo[9,3-a]piridin,
71) 3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5-((S)-1-feniletil)-4H-[1,2,4]triazol,
72) 3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5-((R)-1-feniletil)-4H-[1,2,4]triazol,
73) (-)-8-(4-fluorfenil)-8-metoksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
74) (+)-8-(4-fluorfenil)-8-metoksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
75) (-)-8-metoksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
76) (+)-8-metoksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
77) (-)-8-metoksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-metoksifenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
78) (+)-8-metoksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-metoksifenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
79) 5-[metoksi-(4-metoksifenil)metil]-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-[1,2,4]triazol,
80) 7-(4-fluorfenil)-7-metoksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-6,7-dihidro-5H-pirolo[1,2-b][1,2,4]triazol,
81) 4-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1-(tetrahidrofuran-2-ilmetil)-1H-imidazol,
82) 4-{5-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4H-[1,2,4]triazol-3-il}-4-(3,4,5-trifluorfenil)butan-1-ol,
83) (+)-2-1(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-fenil-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-karbonitril,
84) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-fenil-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-karbonitril,
85) (-)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin-8-karbonitril,
86) (+)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin-8-karbonitril,
87) (+)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a)piridin-8-ilamin,
88) (-)-8-(4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ilamin,
89) 2-{(E)-2-[3-fluoro-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
90) (-)-2-{(E)-2-[3-fluoro-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin-8-ol,
91) (+)-2-{(E)-2-[3-fluoro-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin-8-ol,
92) 2-{(E)-2-[2-fluoro-5-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
93) (+)-2-{(E)-2-[2-fluoro-5-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
94) (-)-2-{(E)-2-[2-fluoro-5-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
95) 2-{(Z)-1-fluoro-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
96) (-)-2-{(Z)-1-fluoro-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
97) (+)-2-{(Z)-1-fluoro-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-fluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
98) (-)-2-{(E)-2-[5-metoksi-6-(4-metil-1H-imidazol-1-il)piridin-3-il]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
99) (+)-2-{(E)-2-[5-metoksi-6-(4-metil-1H-imidazol-1-il)piridin-3-il]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
100) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-7-(3,4,5-trifluorfenil)-6,7-dihidro-5H-pirolo[1,2-b][1,2,9]triazol,
101) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-7-(3,4,5-trifluorfenil)-6,7-dihidro-5H-pirolo[1,2-b][1,2,4]triazol,
102) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-7-(3,4,5-trifluorfenil)-6,7-dihidro-5H-pirolo[1,2-b][1,2,4]triazol-7-ol,
103) (-)-2-{(E)-2-[3-metoksi-9-(4-metil-1H-imidazol-1-il)fenil]vinil}-7-(3,4,5-trifluorfenil)-6,7-dihidro-5H-pirolo[1,2-b][1,2,4]triazol-7-ol,
104) (+)-8-(3,4-difluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro-[1,2,4]triazolo[1,5-a]piridin,
105) (-)-8-(3,4-difluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro-[1,2,4]triazolo[1,5-a]piridin,
106) 4-(4-fluorfenil)-2-((E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil)-4,5,6,7-tetrahidro[1.2.4]triazolo[1,5-a]pirimidin,
107) (+)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil]-5-fenil-5,6,7,8-tetrahidro[1.2.4]triazolo[4,3-a]piridin,
108) (-)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5-fenil-5,6,7,8-tetrahidro[1.2.4]triazolo[4,3-a]piridin,
109) 4-klor-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol,
110) 4-(4-metoksifenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol,
111) 4-(3-metoksifenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil)-1H-imidazol,
112) 4-(2-metoksifenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol,
113) 4-(4-klorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol,
114) 4-(4-bifenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol,
115) 4-(4-propil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-1H-imidazol,
116) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-trifluormetoksifenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
117) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-trifluormetoksifenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
118) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-naftalen-1-il-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
119) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-naftalen-1-il-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
120) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-metoksifenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
121) (-)-2-((E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil)-8-(4-metoksifenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
122) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-trifluormetoksifenil)-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
123) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(4-trifluormetoksifenil)-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
124) (-)-2-((E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil)-8-naftalen-1-il-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
125) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-naftalen-1-il-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
126) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-p-tolil-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c] [1,4]oksazin,
127) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-p-tolil-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c] [1,4]oksazin,
128) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(2,4,6-trifluorfenil)-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
129) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(2,4,6-trifluorfenil)-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
130) (+)-8-(4-bromofenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
131) (-)-8-(4-bromofenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
132) (+)-8-(6-klorpiridin-3-il)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
133) (-)-8-(6-klorpiridin-3-il)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin,
134) (+)-4-(2-{(E)-2-(3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin-8-il)benzonitril,
135) (-)-4-(2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6-dihidro-8H-[1,2,4]triazolo[5,1-c][1,4]oksazin-8-il)benzonitril,
136) (+)-8-(4-klorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
137) (-)-8-(4-klorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
138) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-p-tolil-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
139) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-p-tolil-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
140) (+)-8-(4-klorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
141) (-)-8-(4-klorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-ol,
142) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-p-tolil-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin-8-ol,
143) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-p-tolil-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin-8-ol,
144) (+)-9-{2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-il}benzonitril,
145) (-)-4-{2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-il}benzonitril,
146) (+)-4-(8-hidroksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin-8-il}benzonitril,
147) (-)-4-{8-hidroksi-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin-8-il}benzonitril,
148) {4-{2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin-8-il}fenil}dimetilamin,
149) (S)-8-(4-klorfenil)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]piridin,
150) (R)-8-(4-klorfenil)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]piridin,
151) (+)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]piridin,
152) (-)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(3,4,5-trifluorfenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]piridin,
153) (+)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-7-(3,4,5-trifluorfenil)-6,7-dihidro-5H-pirolo[2,1-c][1,2,4]triazol,
154) (-)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-7-(3,4,5-trifluorfenil)-6,7-dihidro-5H-pirolo[2,1-c][1,2,4]triazol,
155) (S)-3-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4-(3,4,5-trifluorfenil)-6,7,8,4-tetrahidro-5H-[1,2,4]triazolo[4,3-a]azepin,
156) (R)-3-((E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil)-4-(3,4,5-trifluorfenil)-6,7,8,4-tetrahidro-5H-[1,2,4]triazolo[4,3-a]azepin,
157) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4-(3,4,5-trifluorfenil)-6,7,8,4-tetrahidro-5H-[1,2,4]triazolo[1,5-a]azepin,
158) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-4-(3,4,5-trifluorfenil)-6,7,8,4-tetrahidro-5H-[1,2,4]triazolo[1,5-a]azepin,
159) (-)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-fenil-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
160) (+)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-fenil-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin,
161) (-)-8-(2-bromofenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
162) (+)-8-(2-bromofenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
163) 8-(2-bromo-4-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
164) 8-(2-fluorfenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a)piridin,
165) 2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(2-metoksifenil)-5,6,7,8-tetrahidro[1,2,4]triazolo[1,5-a]piridin,
166) 8-(3-bromofenil)-2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil]-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin i
167) 2-{(E)-2-[3-metoksi-4-(4-metil-1H-imidazol-1-il)fenil]vinil}-8-(2-nitrofenil)-5,6,7,8-tetrahidro[1.2.4]triazolo[1,5-a]piridin.
13. Lijek, naznačen time, da kao djelatnu tvar sadrži spoj ili njegovu farmakološki prihvatljivu sol u skladu s jednim od patentnih zahtjeva 1 do 12.
14. Lijek u skladu s patentnim zahtjevom 13, naznačen time, da se koristi za prevenciju ili liječenje bolesti prouzročene beta-amiloidom.
15. Lijek u skladu s patentnim zahtjevom 14, naznačen time, da je bolest prouzročena beta- amiloidom Alzheimerova bolest, demencija, Downov sindrom ili amiloidoza.
16. Spoj formule (I) ili njegova farmakološki prihvatljiva sol u skladu s jednim od patentnih zahtjeva 1 do 12, naznačen time, da se koristi za prevenciju ili liječenje bolesti prouzročene beta-amiloidom.
17. Spoj u skladu s patentnim zahtjevom 16, ili njegova farmakološki prihvatljiva sol, naznačen time, da je bolest prouzročena beta-amiloidom Alzheimerova bolest, senilna demencija, Downov sindrom ili amiloidoza.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78051706P | 2006-03-09 | 2006-03-09 | |
JP2006063562 | 2006-03-09 | ||
US86170206P | 2006-11-30 | 2006-11-30 | |
JP2006322728 | 2006-11-30 | ||
PCT/JP2007/054532 WO2007102580A1 (ja) | 2006-03-09 | 2007-03-08 | 多環式シンナミド誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20120174T1 true HRP20120174T1 (hr) | 2012-03-31 |
Family
ID=38474999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20120174T HRP20120174T1 (hr) | 2006-03-09 | 2012-02-22 | Derivat policikličnog cinamida |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1992618B1 (hr) |
KR (1) | KR101464651B1 (hr) |
AR (1) | AR059955A1 (hr) |
AU (1) | AU2007223158B2 (hr) |
CA (1) | CA2643796A1 (hr) |
CY (1) | CY1112767T1 (hr) |
EA (1) | EA016464B1 (hr) |
GE (1) | GEP20115139B (hr) |
HK (2) | HK1122027A1 (hr) |
HN (1) | HN2008001374A (hr) |
HR (1) | HRP20120174T1 (hr) |
IL (1) | IL193770A (hr) |
MA (1) | MA30268B1 (hr) |
MX (1) | MX2008011221A (hr) |
PL (1) | PL1992618T3 (hr) |
WO (1) | WO2007102580A1 (hr) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005115990A1 (ja) | 2004-05-26 | 2005-12-08 | Eisai R & D Management Co., Ltd. | シンナミド化合物 |
CN100577657C (zh) | 2004-10-26 | 2010-01-06 | 卫材R&D管理有限公司 | 肉桂酰胺化合物的无定形物 |
CA2629745A1 (en) | 2005-11-24 | 2007-05-31 | Eisai R & D Management Co., Ltd. | Morpholine type cinnamide compound |
TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
AR062095A1 (es) | 2006-07-28 | 2008-10-15 | Eisai R&D Man Co Ltd | Profarmaco de compuesto cinamida |
WO2008097538A1 (en) * | 2007-02-08 | 2008-08-14 | Merck & Co., Inc. | Therapeutic agents |
TW200848054A (en) | 2007-02-28 | 2008-12-16 | Eisai R&D Man Co Ltd | Two cyclic oxomorpholine derivatives |
CN101675045B (zh) | 2007-05-11 | 2012-11-28 | 弗·哈夫曼-拉罗切有限公司 | 作为β-淀粉样蛋白调节剂的杂芳基苯胺 |
JP5495331B2 (ja) * | 2007-06-01 | 2014-05-21 | メルク・シャープ・アンド・ドーム・コーポレーション | γセクレターゼ修飾因子 |
US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
KR20100055456A (ko) * | 2007-08-31 | 2010-05-26 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 다환식 화합물 |
EP2217604A1 (en) | 2007-11-05 | 2010-08-18 | Schering Corporation | Gamma secretase modulators |
CA2708151A1 (en) * | 2007-12-11 | 2009-06-18 | Schering Corporation | Gamma secretase modulators |
CA2710477A1 (en) | 2007-12-20 | 2009-07-09 | Envivo Pharmaceuticals, Inc. | Tetrasubstituted benzenes |
AU2008340421B2 (en) | 2007-12-21 | 2013-12-19 | F. Hoffmann-La Roche Ag | Heteroaryl derivatives as orexin receptor antagonists |
ES2375919T3 (es) | 2008-01-11 | 2012-03-07 | F. Hoffmann-La Roche Ag | Moduladores de beta-amiloide. |
CN101952275B (zh) | 2008-02-22 | 2014-06-18 | 弗·哈夫曼-拉罗切有限公司 | β-淀粉样蛋白的调节剂 |
RU2011111534A (ru) * | 2008-08-27 | 2012-10-10 | ЭЙСАЙ Ар энд Ди МЕНЕДЖМЕНТ КО., ЛТД. (JP) | Способ получения определенных цинниамидных соединений |
WO2010040661A1 (en) | 2008-10-09 | 2010-04-15 | F. Hoffmann-La Roche Ag | Modulators for amyloid beta |
EP2356115A1 (en) * | 2008-11-06 | 2011-08-17 | Schering Corporation | Gamma secretase modulators |
WO2010054064A1 (en) * | 2008-11-06 | 2010-05-14 | Schering Corporation | Gamma secretase modulators |
CN102209537A (zh) | 2008-11-10 | 2011-10-05 | 弗·哈夫曼-拉罗切有限公司 | 杂环γ分泌酶调节剂 |
JP2012508748A (ja) | 2008-11-13 | 2012-04-12 | シェーリング コーポレイション | γ−セクレターゼ調節剤 |
AU2009330233A1 (en) * | 2008-12-22 | 2011-07-07 | Merck Sharp & Dohme Corp. | Gamma secretase modulators |
TW201030002A (en) * | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
JP2012051805A (ja) | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | テトラヒドロトリアゾロピリジン誘導体の製造方法 |
EP2401277A1 (en) | 2009-02-26 | 2012-01-04 | Eisai R&D Management Co., Ltd. | Salt of tetrahydrotriazolopyridine derivative and crystal thereof |
CA2753696A1 (en) | 2009-02-26 | 2010-09-02 | Noritaka Kitazawa | Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
JP2012121809A (ja) * | 2009-02-26 | 2012-06-28 | Eisai R & D Management Co Ltd | 多環式化合物の製造法およびその中間体 |
JP2012051807A (ja) * | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | アリールイミダゾール化合物 |
CA2767764A1 (en) * | 2009-07-13 | 2011-01-20 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
US8871760B2 (en) * | 2009-09-21 | 2014-10-28 | Roche Palo Alto Llc | [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators |
CA2784769A1 (en) * | 2010-01-15 | 2011-07-21 | Janssen Pharmaceuticals, Inc. | Novel substituted triazole derivatives as gamma secretase modulators |
US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
EP2542089B1 (en) | 2010-03-05 | 2017-01-18 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
BR112013004746A2 (pt) * | 2010-09-02 | 2016-06-07 | Takeda Pharmaceutical | "composto, medicamento, inibidor da produção de beta-amilóide, modulador de gama-secretase, métodos para inibir a produção de beta-amilóide, para modular gama-secretase, e para prevenir ou tratar deficiência cognitiva branda ou mal de alzheimer, e, uso do composto." |
JP2014012641A (ja) * | 2010-10-29 | 2014-01-23 | Dainippon Sumitomo Pharma Co Ltd | 新規ピリジン誘導体 |
EP2665362B1 (en) * | 2011-01-17 | 2016-03-30 | Karyopharm Therapeutics, Inc. | Olefin containing nuclear transport modulators and uses thereof |
BR112014001933A2 (pt) | 2011-07-29 | 2017-02-21 | Karyopharm Therapeutics Inc | moduladores de transporte nuclear e usos dos mesmos |
KR102022716B1 (ko) | 2011-07-29 | 2019-09-18 | 카리오팜 쎄라퓨틱스, 인코포레이티드 | 하이드라지드 함유 핵 수송 조절인자 및 이의 용도 |
WO2013055793A1 (en) * | 2011-10-12 | 2013-04-18 | University Of Pittsburg-Of The Commonwealth System Of Higher Education | Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer |
SI3404027T1 (sl) | 2012-05-09 | 2020-08-31 | Biogen Ma Inc. | Modulatorji jedrnega transporta in njihova uporaba |
JP6106745B2 (ja) | 2012-05-16 | 2017-04-05 | ヤンセン ファーマシューティカルズ,インコーポレーテッド | (特に)アルツハイマー病の治療に有用な置換3,4−ジヒドロ−2H−ピリド[1,2−a]ピラジン−1,6−ジオン誘導体 |
EP2687528A1 (en) * | 2012-07-17 | 2014-01-22 | Ares Trading S.A. | Fused triazole derivatives as gamma secretase modulators |
AU2013366668B2 (en) | 2012-12-20 | 2017-07-20 | Janssen Pharmaceutica Nv | Novel tricyclic 3,4-dihydro-2H-pyrido[1,2-alpha]pyrazine -1,6-dione derivatives as gamma secretase modulators |
WO2014111457A1 (en) | 2013-01-17 | 2014-07-24 | Janssen Pharmaceutica Nv | Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators |
WO2014144772A1 (en) | 2013-03-15 | 2014-09-18 | Karyopharm Therapeutics Inc. | Methods of promoting wound healing using crm1 inhibitors |
DK3492455T3 (da) | 2013-06-21 | 2023-08-14 | Karyopharm Therapeutics Inc | 1,2,4-triazoler som nukleare transportmodulatorer og anvendelse til behandling af specifikke former for cancer |
JP6564380B2 (ja) | 2013-09-20 | 2019-08-21 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 前立腺癌を治療するための化合物 |
US20160257657A1 (en) | 2013-09-20 | 2016-09-08 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer |
US10562897B2 (en) | 2014-01-16 | 2020-02-18 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
SG10201808624VA (en) | 2014-08-15 | 2018-11-29 | Karyopharm Therapeutics Inc | Polymorphs of selinexor |
WO2017117535A1 (en) | 2015-12-31 | 2017-07-06 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
EP3397633A1 (en) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics, Inc. | Nuclear transport modulators and uses thereof |
US10980806B2 (en) | 2016-03-24 | 2021-04-20 | University of Pittsburgh—of the Commonwealth System of Higher Education | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer |
US11602530B2 (en) | 2016-11-28 | 2023-03-14 | Biogen Ma Inc. | CRM1 inhibitors for treating epilepsy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1257894C (zh) * | 2000-12-04 | 2006-05-31 | 弗·哈夫曼-拉罗切有限公司 | 作为谷氨酸受体拮抗剂的苯基乙烯基或苯基乙炔基衍生物 |
JP2006518738A (ja) * | 2003-02-12 | 2006-08-17 | トランス テック ファーマ,インコーポレイテッド | 治療薬としての置換アゾール誘導体 |
JP4898458B2 (ja) * | 2004-02-12 | 2012-03-14 | トランス テック ファーマ,インコーポレイテッド | 置換アゾール誘導体、組成物及び使用方法 |
WO2005115990A1 (ja) * | 2004-05-26 | 2005-12-08 | Eisai R & D Management Co., Ltd. | シンナミド化合物 |
-
2007
- 2007-03-08 EA EA200870336A patent/EA016464B1/ru not_active IP Right Cessation
- 2007-03-08 AR ARP070100958A patent/AR059955A1/es not_active Application Discontinuation
- 2007-03-08 GE GEAP200710893A patent/GEP20115139B/en unknown
- 2007-03-08 AU AU2007223158A patent/AU2007223158B2/en not_active Ceased
- 2007-03-08 EP EP07738023A patent/EP1992618B1/en active Active
- 2007-03-08 WO PCT/JP2007/054532 patent/WO2007102580A1/ja active Application Filing
- 2007-03-08 CA CA002643796A patent/CA2643796A1/en not_active Abandoned
- 2007-03-08 PL PL07738023T patent/PL1992618T3/pl unknown
- 2007-03-08 MX MX2008011221A patent/MX2008011221A/es active IP Right Grant
- 2007-03-08 KR KR1020087023309A patent/KR101464651B1/ko not_active IP Right Cessation
-
2008
- 2008-08-28 IL IL193770A patent/IL193770A/en not_active IP Right Cessation
- 2008-09-05 HN HN2008001374A patent/HN2008001374A/es unknown
- 2008-09-08 MA MA31220A patent/MA30268B1/fr unknown
-
2009
- 2009-03-11 HK HK09102339.7A patent/HK1122027A1/xx not_active IP Right Cessation
- 2009-06-19 HK HK09105547.8A patent/HK1128085A1/xx not_active IP Right Cessation
-
2012
- 2012-02-16 CY CY20121100165T patent/CY1112767T1/el unknown
- 2012-02-22 HR HR20120174T patent/HRP20120174T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CY1112767T1 (el) | 2016-02-10 |
EP1992618B1 (en) | 2012-01-18 |
CA2643796A1 (en) | 2007-09-13 |
IL193770A0 (en) | 2009-05-04 |
KR101464651B1 (ko) | 2014-11-24 |
HK1128085A1 (en) | 2009-10-16 |
IL193770A (en) | 2012-10-31 |
AR059955A1 (es) | 2008-05-14 |
EP1992618A1 (en) | 2008-11-19 |
EA200870336A1 (ru) | 2009-02-27 |
AU2007223158B2 (en) | 2012-04-12 |
MA30268B1 (fr) | 2009-03-02 |
HK1122027A1 (en) | 2009-05-08 |
PL1992618T3 (pl) | 2012-06-29 |
EA016464B1 (ru) | 2012-05-30 |
MX2008011221A (es) | 2008-09-11 |
KR20080108481A (ko) | 2008-12-15 |
WO2007102580A1 (ja) | 2007-09-13 |
GEP20115139B (en) | 2011-01-10 |
EP1992618A4 (en) | 2010-11-10 |
HN2008001374A (es) | 2011-03-15 |
AU2007223158A1 (en) | 2007-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20120174T1 (hr) | Derivat policikličnog cinamida | |
AU2019203444B2 (en) | Bicyclic lactams and methods of use thereof | |
JP7418395B2 (ja) | Shp2ホスファターゼ阻害剤およびこれらの使用方法 | |
JP6382867B2 (ja) | Trkaキナーゼ阻害剤としてのピロリジニル尿素およびピロリジニルチオ尿素化合物 | |
JP6373978B2 (ja) | イミダゾピロリジノン誘導体および疾患の処置におけるその使用 | |
AU2011240808B2 (en) | 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of JAK kinases | |
AU732455B2 (en) | Substituted 1,2,4-triazolo{3,4-a}phthalazine derivatives as gaba alpha 5 ligands | |
JP6785384B2 (ja) | 新規なヘテロ環化合物、その製造方法およびこれを含む薬学的組成物 | |
JP2019504821A (ja) | ユビキチン特異的プロテアーゼ1阻害剤としてのプリノン | |
ES2271221T3 (es) | Derivados imidazo-pirimidina como ligandos para receptores gaba. | |
JP2018522046A5 (hr) | ||
JP2011516512A5 (ja) | 新規な置換スピロ[シクロアルキル−1,3'−インドール]−2'(1'H)−オン誘導体およびp38マイトジェン活性化タンパク質キナーゼ阻害剤としてのそれらの使用 | |
CA2694401A1 (en) | Polycyclic compound | |
HUE032770T2 (en) | New NK-3 receptor selective antagonist compounds, pharmaceutical compositions and methods for use in NK-3 receptor mediated disorders | |
BG107899A (bg) | Б...нзимидазолови и пиридилимидазолови производни ка'о лиганди на gaba р...-...п'ори | |
HRP20160649T1 (hr) | Novi derivati tienopirimidina, postupci za njihovo pripremanje i njihova terapeutska uporaba | |
CA2521929A1 (en) | Condensed n-heterocyclic compounds and their use as crf receptor antagonists | |
RU2005117383A (ru) | Производные фенилаланина в качестве ингибиторов дипептидилпептидазы для лечения или профилактики диабета | |
WO2017059191A1 (en) | Heteroaryl derivatives as sepiapterin reductase inhibitors | |
JP2011503166A5 (hr) | ||
WO2008072779A1 (ja) | キノキサリン誘導体 | |
WO2003070236A2 (en) | Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents | |
JP2004538316A5 (hr) | ||
ES2550201T3 (es) | Moduladores de la PDE10 | |
JP2024512740A (ja) | 例えばがんの処置のためのSHP2阻害剤としての(S)-1-(5-((ピリジン-3-イル)チオ)ピラジン-2-イル)-4’H,6’H-スピロ[ピペリジン-4,5’-ピロロ[1,2-b]ピラゾール]-4’-アミン誘導体及び同様の化合物 |